ABSTRACT
Volatile solvents exposure can result in various behavioral impairments that have been partly associated to altered adult hippocampal neurogenesis. Despite recent evidence supporting this association, few studies have been devoted to examine the impact on olfactory functioning and olfactory bulb (OB) neurogenesis, although olfactory system is directly in contact with volatile molecules. Thus, this study was designed to evaluate in adult mice the potential modifications of the olfactory functioning after acute (1 day), subchronic (6 weeks) and chronic (12 weeks) exposure to thinner vapor at both behavioral and cellular levels. Firstly, behavioral evaluations showed that chronic thinner exposure impacts on odor detection ability of treated mice but does not affect mice ability to efficiently discriminate between two different odors. Moreover, chronic thinner exposure produces impairment in the olfactory-mediated associative memory. Secondly, analysis of the effects of thinner exposure in the subventricular zone (SVZ) of the lateral ventricle and in the OB revealed that thinner treatments do not induce apoptosis nor glial activation. Thirdly, immunohistochemical quantification of different markers of adult olfactory neurogenesis showed that inhalant treatments do not change the number of proliferating progenitors in the SVZ and the rostral migratory stream (RMS), as well as the number of newborn cells reaching and integrating in the OB circuitry. Altogether, our data highlight that the impaired olfactory performances in chronically-exposed mice are not associated to an alteration of adult neurogenesis in the SVZ-OB system.
Subject(s)
Inhalant Abuse/physiopathology , Neurogenesis/drug effects , Olfaction Disorders/physiopathology , Olfactory Bulb/drug effects , Volatile Organic Compounds/toxicity , Animals , Lateral Ventricles/drug effects , Mice , Smell/drug effectsSubject(s)
Brain/diagnostic imaging , Chlorobenzenes/poisoning , Dementia/psychology , Insecticides/poisoning , Leukoencephalopathies/psychology , Naphthalenes/poisoning , Neurotoxicity Syndromes/psychology , Substance-Related Disorders/psychology , Administration, Oral , Adult , Ataxia/chemically induced , Ataxia/physiopathology , Dementia/chemically induced , Dementia/physiopathology , Female , Humans , Inhalant Abuse/physiopathology , Inhalant Abuse/psychology , Leukoencephalopathies/chemically induced , Leukoencephalopathies/diagnostic imaging , Leukoencephalopathies/physiopathology , Magnetic Resonance Imaging , Neurotoxicity Syndromes/diagnostic imaging , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/physiopathology , Substance-Related Disorders/physiopathologyABSTRACT
BACKGROUND/AIMS: Abuse of toluene products (e.g., glue-sniffing) primarily occurs during adolescence and has been associated with appetite suppression and weight impairments. However, the metabolic phenotype arising from adolescent inhalant abuse has never been fully characterised, and its persistence during abstinence and underlying mechanisms remain unknown. METHODS: Adolescent male Wistar rats (post-natal day 27) were exposed to inhaled toluene (10,000 ppm) (n = 32) or air (n = 48) for 1 h/day, 3 days/week for 4 weeks, followed by 4 weeks of abstinence. Twenty air rats were pair-fed to the toluene group, to differentiate the direct effects of toluene from under-nutrition. Food intake, weight, and growth were monitored. Metabolic hormones were measured after exposure and abstinence periods. Energy expenditure was measured using indirect calorimetry. Adrenal function was assessed using adrenal histology and hormone testing. RESULTS: Inhalant abuse suppressed appetite and increased energy expenditure. Reduced weight gain and growth were observed in both the toluene and pair-fed groups. Compared to the pair-fed group, and despite normalisation of food intake, the suppression of weight and growth for toluene-exposed rats persisted during abstinence. After exposure, toluene-exposed rats had low fasting blood glucose and insulin compared to the air and pair-fed groups. Consistent with adrenal insufficiency, adrenal hypertrophy and increased basal adrenocorticotropic hormone were observed in the toluene-exposed rats, despite normal basal corticosterone levels. CONCLUSIONS: Inhalant abuse results in negative energy balance, persistent growth impairment, and endocrine changes suggestive of adrenal insufficiency. We conclude that adrenal insufficiency contributes to the negative energy balance phenotype, potentially presenting a significant additional health risk for inhalant users.
Subject(s)
Adrenal Gland Diseases/chemically induced , Growth Disorders/chemically induced , Inhalant Abuse/complications , Metabolic Diseases/chemically induced , Sexual Maturation , Adolescent , Adolescent Behavior/drug effects , Adolescent Behavior/physiology , Adolescent Development/drug effects , Adrenal Gland Diseases/metabolism , Adrenal Gland Diseases/physiopathology , Adrenal Glands/physiopathology , Animals , Appetite/drug effects , Body Weight/drug effects , Disease Models, Animal , Eating/drug effects , Growth Disorders/metabolism , Growth Disorders/physiopathology , Humans , Inhalant Abuse/metabolism , Inhalant Abuse/pathology , Inhalant Abuse/physiopathology , Male , Metabolic Diseases/metabolism , Metabolic Diseases/physiopathology , Motor Activity/drug effects , Phenotype , Rats , Rats, Wistar , Sexual Maturation/drug effects , Sexual Maturation/physiology , Toluene/toxicityABSTRACT
Inhalants, including toluene, target the addiction neurocircuitry and are often one of the first drugs of abuse tried by adolescents. The medial prefrontal cortex (mPFC) is involved in regulating goal-directed/reward-motivated behaviors and different mPFC sub-regions have been proposed to promote (prelimbic, PRL) or inhibit (infralimbic, IL) these behaviors. While this dichotomy has been studied in the context of other drugs of abuse, it is not known whether toluene exposure differentially affects neurons within PRL and IL regions. To address this question, we used whole-cell electrophysiology and determined the intrinsic excitability of PRL and IL pyramidal neurons in adolescent rats 24 h following a brief exposure to air or toluene vapor (10 500 p.p.m.). Prior to exposure, fluorescent retrobeads were injected into the NAc core (NAcc) or shell (NAcs) sub-regions to identify projection-specific mPFC neurons. In toluene treated adolescent rats, layer 5/6 NAcc projecting PRL (PRL5/6) neurons fired fewer action potentials and this was associated with increased rheobase, increased spike duration, and reductions in membrane resistance and amplitude of the Ih current. No changes in excitability were observed in layer 2/3 NAcc projecting PRL (PRL2/3) neurons. In contrast to PRL neurons, layer 5 IL (IL5) and layer 2/3 (IL2/3) NAcc projecting neurons showed enhanced firing in toluene-exposed animals and in IL5 neurons, this was associated with a reduction in rheobase and AHP. For NAcs projecting neurons, toluene exposure significantly decreased firing of IL5 neurons and this was accompanied by an increased rheobase, increased spike duration, and reduced Ih amplitude. The intrinsic excitability of PRL5, PRL2/3, and IL2/3 neurons projecting to the NAcs was not affected by exposure to toluene. The changes in excitability observed 24 h after toluene exposure were not observed when recordings were performed 7 days after the exposure. Finally, there were no changes in intrinsic excitability of any region in rats exposed to toluene as adults. These findings demonstrate that specific projections of the reward circuitry are uniquely susceptible to the effects of toluene during adolescence supporting the idea that adolescence is a critical period of the development that is vulnerable to drugs of abuse.
Subject(s)
Inhalant Abuse/physiopathology , Prefrontal Cortex/drug effects , Prefrontal Cortex/physiology , Solvents/administration & dosage , Toluene/administration & dosage , Age Factors , Animals , Male , Organ Culture Techniques , Rats , Rats, Sprague-Dawley , Synaptic Transmission/drug effects , Synaptic Transmission/physiologyABSTRACT
INTRODUCTION: Cue-induced craving is known to be associated with a higher risk of relapse, wherein drug-specific cues become conditioned stimuli, eliciting conditioned responses. Cue-reactivity paradigm are important tools to study psychological responses and functional neuroimaging changes. However, till date, there has been no specific study or a validated paradigm for inhalant cue-induced craving research. The study aimed to develop and validate visual cue stimulus for inhalant cue-associated craving. METHOD: The first step (picture selection) involved screening and careful selection of 30 cue- and 30 neutral-pictures based on their relevance for naturalistic settings. In the second step (time optimization), a random selection of ten cue-pictures each was presented for 4s, 6s, and 8s to seven adolescent male inhalant users, and pre-post craving response was compared using a Visual Analogue Scale(VAS) for each of the picture and time. In the third step (validation), craving response for each of 30 cue- and 30 neutral-pictures were analysed among 20 adolescent inhalant users. RESULTS: Findings revealed a significant difference in before and after craving response for the cue-pictures, but not neutral-pictures. Using ROC-curve, pictures were arranged in order of craving intensity. Finally, 20 best cue- and 20 neutral-pictures were used for the development of a 480s visual cue paradigm. CONCLUSION: This is the first study to systematically develop an inhalant cue picture paradigm which can be used as a tool to examine cue induced craving in neurobiological studies. Further research, including its further validation in larger study and diverse samples, is required.
Subject(s)
Craving/physiology , Cues , Inhalant Abuse/physiopathology , Neuropsychological Tests/standards , Pattern Recognition, Visual/physiology , Psychometrics/methods , Adolescent , Humans , MaleABSTRACT
BACKGROUND: "Legal highs" are novel psychoactive substances that have evaded statutory control. Synthetic cannabinoid compounds with adamantane moieties have recently been identified, which have high potency at target receptors and are undetectable on conventional toxicology testing. However, little is known about any harmful effects, and their potential to cause serious ill health. We describe a case of myocardial infarction following the use of this class of drug. CASE PRESENTATION: We report the case of a 39-year-old man admitted after an out-of-hospital cardiac arrest, in whom ECG and elevated cardiac enzymes confirmed ST-elevation myocardial infarction. Normal coronary perfusion was restored after thrombectomy and coronary artery stenting. In the hours preceding his admission, the patient is known to have consumed the legal high product "Black Mamba". Subsequent urine testing confirmed the presence of an adamantyl-group synthetic cannabinoid, whilst cannabis, cocaine, amphetamines and other drugs of abuse were not detected. CONCLUSION: The use of legal highs is being increasingly recognised, but the chemical compositions and physiological effects of these drugs are poorly characterised and are continually changing. Synthetic cannabinoids, rarely identified on toxicological testing, can be linked to serious adverse cardiovascular events. This case highlights the importance of testing for novel psychoactive compounds, and recognising their potential to cause life-threatening conditions.
Subject(s)
Adamantane/toxicity , Cannabinoids/toxicity , Designer Drugs/toxicity , Inhalant Abuse/physiopathology , Myocardial Infarction/etiology , Psychotropic Drugs/toxicity , Adamantane/administration & dosage , Adamantane/urine , Administration, Inhalation , Adult , Cannabinoids/administration & dosage , Cannabinoids/urine , Designer Drugs/administration & dosage , Designer Drugs/analysis , Diagnosis, Differential , Emergency Medical Services , England , Humans , Inhalant Abuse/diagnosis , Inhalant Abuse/urine , Male , Myocardial Infarction/therapy , Psychotropic Drugs/administration & dosage , Psychotropic Drugs/urine , Toxicokinetics , Treatment OutcomeSubject(s)
Cheilitis/etiology , Edema/etiology , Inhalant Abuse/diagnosis , Adolescent , Aerosol Propellants/toxicity , Cheilitis/chemically induced , Cheilitis/drug therapy , Cheilitis/physiopathology , Diagnosis, Differential , Edema/chemically induced , Edema/drug therapy , Edema/physiopathology , Finger Injuries/chemically induced , Finger Injuries/etiology , Frostbite/chemically induced , Frostbite/etiology , Glossitis/chemically induced , Glossitis/drug therapy , Glossitis/etiology , Glossitis/physiopathology , Humans , Inhalant Abuse/physiopathology , Male , Self Report , Severity of Illness Index , Treatment OutcomeABSTRACT
The study of features of the nervous system functioning with a complex of physiological methods in adolescents using inhalants has detected the significant functional asymmetry of hemispheres, imbalance and lability of nervous processes, domination of medium-weak and weak response of the nervous system, low speed of response, poor dynamics of nervous processes, disturbance of regulation and control of psychic activity. It has been proposed to use assessment of the functional status of the nervous system during inhalant in medical-diagnostic practice for development of individual correction programs.
Subject(s)
Inhalant Abuse/physiopathology , Inhalant Abuse/psychology , Nervous System/physiopathology , Adolescent , Child , Humans , Inhalant Abuse/diagnosis , Male , Psychophysiology/methodsSubject(s)
Central Nervous System/drug effects , Chlorofluorocarbons, Methane/adverse effects , Household Products/adverse effects , Inhalant Abuse/diagnosis , Juvenile Delinquency , Substance Abuse Detection , Adult , Air Conditioning/instrumentation , Chlorofluorocarbons, Methane/administration & dosage , Chlorofluorocarbons, Methane/pharmacology , Cognition Disorders/chemically induced , Euphoria , Humans , Inhalant Abuse/complications , Inhalant Abuse/physiopathology , Male , Prisoners/psychology , Young AdultABSTRACT
Inhalation of vapors from toluene-containing products results in euphoria accompanied by a variety of cognitive impairments and motor dysfunctions. The profound behavioral changes observed during and following toluene inhalation suggest changes in the activity of cells in potentially many brain regions; however, a comprehensive assessment of the neuroanatomical structures activated by toluene vapor has not been completed. Thus in the present study we systematically mapped in over 140 brain structures the distribution of c-Fos immunoreactivity (c-Fos IR), a proxy for neural activation, following exposure to an abuse-like concentration (~5000 ppm) of toluene vapor for 0, 5, 10 or 30 min. Quantitative analyses revealed increases in c-Fos IR in about one-third of the brain structures examined, with most of these structures significantly activated only after prolonged toluene exposure. The majority of brain structures activated by toluene were found in the forebrain and midbrain, with particularly pronounced activation in nuclei implicated in the processing of rewarding, emotional, and olfactory stimuli, and those controlling motor output. These structures included the ventral tegmental area, nucleus accumbens, select regions of the amygdala and hypothalamus, cingulate cortex, olfactory nuclei, piriform cortex, secondary motor cortex and caudate-putamen. In contrast, all subregions of the hippocampus and most thalamic nuclei were not significantly activated by toluene vapor. In the brainstem, effects of toluene vapor were restricted to select nuclei in the pons. The pattern of c-Fos IR evoked by inhalation of toluene vapor appears distinct from other psychoactive substances, consistent with the unique and complex behavioral outcomes associated with acute toluene inhalation.
Subject(s)
Behavior, Animal/drug effects , Brain/drug effects , Disease Models, Animal , Inhalant Abuse/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Toluene/toxicity , Acute Disease , Administration, Inhalation , Animals , Behavior, Animal/physiology , Biomarkers/metabolism , Brain/physiopathology , Immunohistochemistry , Inhalant Abuse/diagnosis , Inhalant Abuse/physiopathology , Male , Rats , Rats, Sprague-Dawley , Solvents/toxicityABSTRACT
More than 22 million Americans age 12 and older have used inhalants, and every year more than 750,000 use inhalants for the first time. Despite the substantial prevalence and serious toxicities of inhalant use, it has been termed "the forgotten epidemic." Inhalant abuse remains the least-studied form of substance abuse, although research on its epidemiology, neurobiology, treatment, and prevention has accelerated in recent years. This review examines current findings in these areas, identifies gaps in the research and clinical literatures pertaining to inhalant use, and discusses future directions for inhalant-related research and practice efforts.